Literature DB >> 30995345

Loss of the Vitamin D Receptor in Human Breast Cancer Cells Promotes Epithelial to Mesenchymal Cell Transition and Skeletal Colonization.

Konstantin Horas1, Yu Zheng1, Colette Fong-Yee1, Eugenie Macfarlane1, Jeline Manibo1, Yunzhao Chen1, Jeremy Qiao1, Mingxuan Gao1, Nancy Haydar2, Michelle M McDonald2, Peter I Croucher2, Hong Zhou1, Markus J Seibel1.   

Abstract

Expression of the vitamin D receptor (VDR) is thought to be associated with neoplastic progression. However, the role of the VDR in breast cancer metastasis to bone and the molecular mechanisms underlying this process are unknown. Employing a rodent model (female Balb/c nu/nu mice) of systemic metastasis, we here demonstrate that knockdown of the VDR strongly increases the metastatic potential of MDA-MB-231 human breast cancer cells to bone, resulting in significantly greater skeletal tumor burden. Ablation of VDR expression promotes cancer cell mobility (migration) and invasiveness, thereby facilitating skeletal colonization. Mechanistically, these changes in tumor cell behavior are attributable to shifts in the expression of proteins involved in cell adhesion, proliferation, and cytoskeletal organization, patterns characteristic for epithelial-to-mesenchymal cell transition (EMT). In keeping with these experimental findings, analyses of human breast cancer specimens corroborated the association between VDR expression, EMT-typical changes in protein expression patterns, and clinical prognosis. Loss of the VDR in human breast cancer cells marks a critical point in oncogenesis by inducing EMT, promoting the dissemination of cancer cells, and facilitating the formation of tumor colonies in bone.
© 2019 American Society for Bone and Mineral Research. © 2019 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BONE METASTASIS; BREAST CANCER; BREAST CANCER METASTASIS; VITAMIN D RECEPTOR

Year:  2019        PMID: 30995345     DOI: 10.1002/jbmr.3744

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  10 in total

1.  KMT2D loss drives aggressive tumor phenotypes in cutaneous squamous cell carcinoma.

Authors:  Cara Dauch; Sharon Shim; Matthew Wyatt Cole; Nijole C Pollock; Abigail J Beer; Johnny Ramroop; Victoria Klee; Dawn C Allain; Reena Shakya; Sue E Knoblaugh; Jesse Kulewsky; Amanda Ewart Toland
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 5.942

2.  Humanized bone facilitates prostate cancer metastasis and recapitulates therapeutic effects of zoledronic acid in vivo.

Authors:  Marietta Landgraf; Christoph A Lahr; Alvaro Sanchez-Herrero; Christoph Meinert; Ali Shokoohmand; Pamela M Pollock; Dietmar W Hutmacher; Abbas Shafiee; Jacqui A McGovern
Journal:  Bone Res       Date:  2019-10-21       Impact factor: 13.567

Review 3.  Vitamin D, Th17 Lymphocytes, and Breast Cancer.

Authors:  Beata Filip-Psurska; Honorata Zachary; Aleksandra Strzykalska; Joanna Wietrzyk
Journal:  Cancers (Basel)       Date:  2022-07-27       Impact factor: 6.575

4.  Atropine Is a Suppressor of Epithelial-Mesenchymal Transition (EMT) That Reduces Stemness in Drug-Resistant Breast Cancer Cells.

Authors:  Emad A Ahmed; Mayyadah A Alkuwayti; Hairul-Islam M Ibrahim
Journal:  Int J Mol Sci       Date:  2022-08-30       Impact factor: 6.208

5.  Levels of Vitamin D and Expression of the Vitamin D Receptor in Relation to Breast Cancer Risk and Survival.

Authors:  Linnea Huss; Salma Tunå Butt; Signe Borgquist; Karin Elebro; Malte Sandsveden; Jonas Manjer; Ann Rosendahl
Journal:  Nutrients       Date:  2022-08-16       Impact factor: 6.706

6.  Editorial: The bone/bone marrow microenvironment: A hub for immune regulation of the tumor cells fate.

Authors:  Konstantin Horas; Ciro Menale; Antonio Maurizi
Journal:  Front Immunol       Date:  2022-08-31       Impact factor: 8.786

7.  Vitamin D Regulates CXCL12/CXCR4 and Epithelial-to-Mesenchymal Transition in a Model of Breast Cancer Metastasis to Lung.

Authors:  Jiarong Li; Aimée-Lee Luco; Anne Camirand; René St-Arnaud; Richard Kremer
Journal:  Endocrinology       Date:  2021-07-01       Impact factor: 4.736

8.  Vitamin D receptor knockdown attenuates the antiproliferative, pro‑apoptotic and anti‑invasive effect of vitamin D by activating the Wnt/β‑catenin signaling pathway in papillary thyroid cancer.

Authors:  Rui Pang; Ye Xu; Xiaonan Hu; Bo Liu; Jiawei Yu
Journal:  Mol Med Rep       Date:  2020-09-17       Impact factor: 2.952

Review 9.  The role of vitamin D and vitamin D deficiency in orthopaedics and traumatology-a narrative overview of the literature.

Authors:  Gerrit S Maier; Manuel Weissenberger; Maximilian Rudert; Klaus E Roth; Konstantin Horas
Journal:  Ann Transl Med       Date:  2021-06

10.  Vitamin D and Breast Cancer: Mechanistic Update.

Authors:  JoEllen Welsh
Journal:  JBMR Plus       Date:  2021-12-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.